Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
BDNF-amyloid-Frontiers in molecular neuroscience · 2026
Review
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Lucija TudorLaboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Ruder Boskovic Institute, 10000 Zagreb, Croatia.ORCID 0000-0002-9125-406X
Alja Videtic PaskaCentre for Functional Genomics and Biochips, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0002-1182-5417
Marcela KonjevodLaboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Ruder Boskovic Institute, 10000 Zagreb, Croatia.
Nikola BalicLaboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Ruder Boskovic Institute, 10000 Zagreb, Croatia.ORCID 0009-0003-2627-3832
Matea Nikolac PerkovicLaboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Ruder Boskovic Institute, 10000 Zagreb, Croatia.ORCID 0000-0002-3113-0778
Suzana UzunDepartment for Biological Psychiatry and Psychogeriatry, University Psychiatric Hospital Vrapce, 10000 Zagreb, Croatia.
Barbara VuicLaboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Ruder Boskovic Institute, 10000 Zagreb, Croatia.
Tina MilosLaboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Ruder Boskovic Institute, 10000 Zagreb, Croatia.
Gordana Nedic ErjavecLaboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Ruder Boskovic Institute, 10000 Zagreb, Croatia.ORCID 0000-0002-0787-9340
Ninoslav MimicaDepartment for Biological Psychiatry and Psychogeriatry, University Psychiatric Hospital Vrapce, 10000 Zagreb, Croatia.ORCID 0000-0003-4552-0547
Katarina KouterInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0002-1051-959X
Dubravka Svob StracLaboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Ruder Boskovic Institute, 10000 Zagreb, Croatia.ORCID 0000-0001-6200-2405
Funding
Croatian Science Foundation IP-2019-573 04-6100
6 · The paper itself
Abstract
Brain-derived neurotrophic factor (BDNF) plays a crucial role in cognitive functions and dementia. In individuals with mild cognitive impairment (MCI) and dementia, we have investigated
Indexed as
Brain-Derived Neurotrophic FactorCognitive DysfunctionDementiaDNA MethylationAgedAged, 80 and overBiomarkersFemaleGenotypeHumansMaleMiddle AgedPolymorphism, Single NucleotidePromoter Regions, GeneticRNA, MessengerBDNF protein, humanBiomarkersBrain-Derived Neurotrophic FactorRNA, MessengerBDNFdementiaDNA methylationgene and protein expressionMCIVal66Met polymorphism
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.